Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells

Bruce A Stanton1, Bonita Coutermarsh1, Roxanna Barnaby1

  • 1Department of Microbiology and Immunology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.

Plos One
|May 29, 2015
PubMed
Abstract

Insights

Pseudomonas aeruginosa infection reduces the effectiveness of CFTR modulator drugs like VX-809 and VX-770 in cystic fibrosis (CF) patients. This bacterial lung infection impairs drug-stimulated chloride secretion, potentially explaining modest clinical trial results.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Genetics

Background:

  • Cystic Fibrosis (CF) affects 85% of adult patients with chronic lung infections by *Pseudomonas aeruginosa*.
  • P. aeruginosa infection reduces wild-type CFTR chloride secretion in airway epithelial cells.
  • Investigational drugs VX-809 and VX-770 improve F508del-CFTR chloride secretion and FEV1 in CF patients.

Purpose of the Study:

  • To investigate the impact of *P. aeruginosa* infection on VX-809 and VX-770 stimulated F508del-CFTR chloride secretion.
  • To determine if *P. aeruginosa* reduces the clinical efficacy of these CFTR modulator drugs.

Main Methods:

  • Exposure of F508del-CFBE and primary CF-HBE cells to VX-809 alone or in combination with VX-770.
  • Measurement of F508del-CFTR chloride secretion using Ussing chambers.
  • Assessment of F508del-CFTR abundance via cell surface biotinylation and western blot analysis.

Main Results:

  • *P. aeruginosa* (including clinical isolates) significantly reduced VX-809 and VX-809 + VX-770 stimulated F508del-CFTR chloride secretion.
  • Bacterial infection also decreased plasma membrane F508del-CFTR levels.
  • Multiple strains of *P. aeruginosa* demonstrated this inhibitory effect.

Conclusions:

  • *P. aeruginosa* infection diminishes the chloride secretion stimulated by VX-809 and VX-809 + VX-770 in F508del-CFTR cells.
  • This interaction may partially explain the modest clinical efficacy observed with VX-809 + VX-770 in CF patients.
  • Targeting *P. aeruginosa* infection could enhance the effectiveness of CFTR modulator therapies.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
912
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
636